# EDGAR Filing Document

**Accession Number:** 0000875320
**File Stem:** 0000875320-26-000154
**Filing Date:** 2026-4
**Character Count:** 2445
**Document Hash:** 5070d5db1828cf98e874d9476a312061
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000875320-26-000154.hdr.sgml**: 20260402

**ACCESSION NUMBER**: 0000875320-26-000154

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20260402

**DATE AS OF CHANGE**: 20260402

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VERTEX PHARMACEUTICALS INC / MA
- **CENTRAL INDEX KEY:** 0000875320
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 043039129
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-19319
- **FILM NUMBER:** 26833256

**BUSINESS ADDRESS:**
- **STREET 1:** 50 NORTHERN AVENUE
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 6173416393

**MAIL ADDRESS:**
- **STREET 1:** 50 NORTHERN AVENUE
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 14A**

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

⌧&nbsp;&nbsp;&nbsp;&nbsp;Filed by the Registrant &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;□ Filed by a Party other than the Registrant

---

| | |
|:---|:---|
| **Check the appropriate box:** | **Check the appropriate box:** |
| □ | &nbsp;&nbsp;**Preliminary Proxy Statement** |
| □ | &nbsp;&nbsp;**Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** |
| □ | &nbsp;&nbsp;**Definitive Proxy Statement** |
| ⌧ | &nbsp;&nbsp;**Definitive Additional Materials** |
| □ | &nbsp;&nbsp;&nbsp;**Soliciting Material under §240.14a-12** |

---

![a435534-1_vertexxlogoa.jpg](a435534-1_vertexxlogoa.jpg)

**Vertex Pharmaceuticals Incorporated**

(Name of Registrant as Specified In Its Charter)

---

| | |
|:---|:---|
| **Payment of Filing Fee (Check all boxes that apply):** | **Payment of Filing Fee (Check all boxes that apply):** |
| ⌧ | **No fee required.** |
| □ | **Fee paid previously with preliminary materials.** |
| □ | **Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.** |

---

------

![a2026finalnotice_pagex1a.jpg](a2026finalnotice_pagex1a.jpg)

------

![a2026finalnotice_pagex2a.jpg](a2026finalnotice_pagex2a.jpg)

<br>